Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CREB3L1 |
| Upstream (Parents) |
|---|
| (<<) AKT1 → CREB3L1 |
| (<<) BMP1 → CREB3L1 |
| (<<) CREB3L4 → CREB3L1 |
| (<<) EFEMP2 → CREB3L1 |
| (<<) GNAI2 → CREB3L1 |
| (<<) ILK → CREB3L1 |
| (<<) ISLR → CREB3L1 |
| (<<) ITGA5 → CREB3L1 |
| (<<) MLPH → CREB3L1 |
| (<<) MMP2 → CREB3L1 |
| (<<) MN1 → CREB3L1 |
| (<<) MXRA8 → CREB3L1 |
| (<<) PIP5K1C → CREB3L1 |
| (<<) PLAT → CREB3L1 |
| (<<) PLAU → CREB3L1 |
| (<<) RHOC → CREB3L1 |
| (<<) SPDEF → CREB3L1 |
| (<<) STX1A → CREB3L1 |
| (<<) THY1 → CREB3L1 |
| (<<) TMEM45B → CREB3L1 |
| Downstream (Children) |
|---|
| CREB3L1 → ACAT2 (>>) |
| CREB3L1 → ALOX15B (>>) |
| CREB3L1 → APH1B (>>) |
| CREB3L1 → ASNS (>>) |
| CREB3L1 → ATP7B (>>) |
| CREB3L1 → BCAM (>>) |
| CREB3L1 → BCL3 (>>) |
| CREB3L1 → CFL2 (>>) |
| CREB3L1 → CSTA (>>) |
| CREB3L1 → DMPK (>>) |
| CREB3L1 → DUSP10 (>>) |
| CREB3L1 → ELF5 (>>) |
| CREB3L1 → FAM46B (>>) |
| CREB3L1 → ITGB6 (>>) |
| CREB3L1 → JUNB (>>) |
| CREB3L1 → LEMD1 (>>) |
| CREB3L1 → LRCH4 (>>) |
| CREB3L1 → LYAR (>>) |
| CREB3L1 → MAP3K12 (>>) |
| CREB3L1 → MST1R (>>) |
| CREB3L1 → MYC (>>) |
| CREB3L1 → MYCN (>>) |
| CREB3L1 → NCOA7 (>>) |
| CREB3L1 → NFIB (>>) |
| CREB3L1 → PLCD3 (>>) |
| CREB3L1 → RARA (>>) |
| CREB3L1 → RDH16 (>>) |
| CREB3L1 → ROR2 (>>) |
| CREB3L1 → RPS12 (>>) |
| CREB3L1 → SOX2 (>>) |
| CREB3L1 → SPRY4 (>>) |
| CREB3L1 → TFF1 (>>) |
| CREB3L1 → TM4SF1 (>>) |
| CREB3L1 → TRIB3 (>>) |
| CREB3L1 → VTCN1 (>>) |
| CREB3L1 → WNT5A (>>) |
| CREB3L1 → ZNF750 (>>) |
